To further explore the connections between B2M expression and CD8+ T cell‐mediated anti‐tumor effects, we constructed B2M‐Sh1 and B2M‐Sh2 plasmids and verified their knockdown efficiency using qPCR and western blots (Figure 5A,B). The gene discussed is CD8A; the disease is neoplasm.